Christopher Mapperley

737 citations
4 papers · 135 · h-index 4

Impact in

    • Cancer-related molecular mechanisms research
    • RNA modifications and cancer
    • Cancer-related gene regulation
    • RNA Research and Splicing
    • Epigenetics and DNA Methylation

Papers in

    • RNA modifications and cancer 2
    • Epigenetics and DNA Methylation 1
    • RNA Research and Splicing 1
    • Histone Deacetylase Inhibitors Research 1
    • Acute Myeloid Leukemia Research 2
    • Hematopoietic Stem Cell Transplantation 1

Christopher Mapperley

4 papers receiving 135 citations

Peers

Christopher Mapperley
Comparison fields: 5 of 23
  • Cancer Research 59
  • Molecular Biology 118
  • Hematology 19
  • Immunology 20
  • Oncology 13
Replace Andrea Tavosanis with:
Andrea Tavosanis United Kingdom
Jesús Alfonso López Sotélo Colombia
Andoni Garitano-Trojaola Germany
Gregory Ferenchak United States
Luc de Waal United States
Saroj Gourkanti United States
Evan Biederstedt United States
Maximilian Schönung Germany
Aisha Jibril United Kingdom
Buys de Barbanson Netherlands
Christopher Mapperley relative to Andrea Tavosanis United Kingdom Andrea Tavosanis's profile →
Citations per field
00.5×1.6×
Andrea Tavosanis · 1×
Citations per year

Countries citing papers authored by Christopher Mapperley

Since Specialization
Citations

This map shows the geographic impact of Christopher Mapperley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Mapperley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Mapperley more than expected).

Fields of papers citing papers by Christopher Mapperley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Mapperley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Mapperley. The network helps show where Christopher Mapperley may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Mapperley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Mapperley Line = papers co-authored together Christopher Mapperley links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1 2020106
2 202314
3 202110
4 20225

About Christopher Mapperley

Christopher Mapperley is a scholar working on Molecular Biology, Hematology, Pulmonary and Respiratory Medicine, Cancer Research and Infectious Diseases, having authored 4 papers that have together received 135 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), RNA modifications and cancer (2 papers), Ferroptosis and cancer prognosis (1 paper), Epigenetics and DNA Methylation (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Cancer-related molecular mechanisms research (1 paper), RNA Research and Splicing (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (59 citations), Molecular Biology (118 citations), Hematology (19 citations), Immunology (20 citations) and Oncology (13 citations). Christopher Mapperley has collaborated with scholars based in United Kingdom, Australia and Ireland. Frequent co-authors include Hannah Lawson, Kamil R. Kranc, Louie N. van de Lagemaat, Andrea Tavosanis, Junho Choe, Dónal O’Carroll, Alex von Kriegsheim, Christian Much, Daniela S. Krause and Marcos Morgan. Their work appears in journals such as The Journal of Experimental Medicine, Biology Open, Nature Communications and Stem Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact